Medical technology company Micropos Medical says that the company’s rights issue of SEK 25.0 million was oversubscribed by 17 percent, corresponding to a subscription rate of just over 117 percent.The company will thus receive approximately SEK 24.5 million after issue costs of around SEK 0.5 million. The issue was subscribed to 60 percent with the support of subscription rights."It is fantastic that we have such strong support among our existing shareholders," says CEO Richard Forsberg.According to Forsberg, the capital will be used to continue the work of establishing SBRT as a treatment method for prostate cancer as well as the commercialization of the Raypilot system.